Related Experiment Video
Updated: Aug 2, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A
Erin F Barreto1, Pooja N Chitre2, Kathleen H Pine3
1Department of Pharmacy, Mayo Clinic, Rochester, Minnesota.
Beta-lactam therapeutic drug monitoring (BL TDM) improves critically ill patient outcomes but has low hospital adoption. Successful implementation requires focusing on individual internalization of BL TDM and organizational support.
Area of Science:
- Pharmacology and Clinical Pharmacy
- Implementation Science
- Critical Care Medicine
Background:
- Beta-lactam therapeutic drug monitoring (BL TDM) can enhance outcomes for critically ill patients.
- Despite benefits, BL TDM is implemented in only 10%-20% of hospitals.
- Understanding provider perceptions is crucial for successful BL TDM implementation.
Purpose of the Study:
- To characterize provider perceptions of BL TDM.
- To identify key considerations for implementing BL TDM in clinical practice.
- To explore barriers and facilitators to BL TDM adoption.
Main Methods:
- A sequential mixed-methods study was conducted from 2020 to 2021.
- Surveys and semistructured interviews were administered to diverse stakeholders at three academic medical centers.
- Implementation science frameworks were used to contextualize findings.
Main Results:
- Most survey respondents found BL TDM relevant, improving medication effectiveness and safety.
- Two key implementation themes emerged: individual internalization and organizational features.
- Individual internalization, influenced by evidence and expertise, was more complex for BL TDM than other antibiotics.
Conclusions:
- Provider enthusiasm for BL TDM is high.
- Implementation barriers extend beyond assay availability, encompassing individual and organizational factors.
- Focusing on individual internalization is key to improving BL TDM adoption.
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management
Errors occurring during blood pressure monitoring
Several factors...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

